• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LI Hui, ZHAO Yueqing, JIANG Niyanhan, CHENG Zeneng. A new method based on flow-through cell apparatus to evaluate dissolution consistency of nimodipine tablets[J]. Journal of China Pharmaceutical University, 2018, 49(3): 301-309. DOI: 10.11665/j.issn.1000-5048.20180308
Citation: LI Hui, ZHAO Yueqing, JIANG Niyanhan, CHENG Zeneng. A new method based on flow-through cell apparatus to evaluate dissolution consistency of nimodipine tablets[J]. Journal of China Pharmaceutical University, 2018, 49(3): 301-309. DOI: 10.11665/j.issn.1000-5048.20180308
shu

A new method based on flow-through cell apparatus to evaluate dissolution consistency of nimodipine tablets

More Information
    Graphical Abstract
    • Abstract
  • A new method of dissolution test was established to better simulate the in vivo dissolution behavior of drugs from preparations and to distinguish the quality difference between drug preparations. With flow-through cell being chosen to be the dissolution apparatus and nimodipine tablet to be the model drugs, this study developed, on the basis of IVIVC theory, a new dissolution method which was subsequently used to evaluate the dissolution consistency of domestically produced nimodipine tablet as test preparation and its reference preparation. Meanwhile, conventional four-dissolution-curves method based on paddle apparatus was selected for comparison to evaluate the efficiency of the new dissolution method. The results indicated that the new dissolution method not only had a good correlation with the in vivo process of drugs, but also could reveal the internal quality differences between pharmaceutical preparations effectively. This research will provide further theoretical support for the application of flow-through cell apparatus in IVIVC study.
    • FullText(HTML)
    • References (23)
  • [1]
    Anand O,Lawrence XY,Conner DP,et al.Dissolution testing for generic drugs:an FDA perspective[J].AAPS J,2011,13(3):328.
    [2]
    Tsume Y,Matsui K,Searls AL,et al.The impact of supersaturation level for oral absorption of BCS class IIb drugs,dipyridamole and ketoconazole,using in vivo predictive dissolution system:gastrointestinal simulator(GIS)[J].Eur J Pharm Sci,2017,102(5):126-139.
    [3]
    Li ZQ,He X,Liu CX.Recent advances in drug dissolution/permeation synchronous evaluation technologies based on physiological characteristics of gastrointestinal tract [J].Acta Pharm Sin(药学学报),2016,51(10):1540-1550.
    [4]
    U. S. Food and Drug Administration. Guidance for industry,extended release oral dosage forms:development,evaluation,and application of in vitro/in vivo correlations[EB/OL].(1997-09)[2017-11-13] .https://www.fda.gov/downloads/dru-gs/guidAncecomplianceregulatoryinformation/guidances/ucm070239.pdf.
    [5]
    Gite S,Chogale M,Patravale V.Development and validation of a discriminating dissolution method for atorvastatin delayed-release nanoparticles using a flow through cell:a comparative study using USP apparatus 4 and 1[J].Dissolut Technol,2016,23(2):14-20.
    [6]
    Prajapat MD,Patel NJ,Bariya A,et al.Formulation and evaluation of self-emulsifying drug delivery system for nimodipine,a BCS class II drug[J].J Drug Deliv Sci Tec,2017,39(6):59-68.
    [7]
    Margolskee A,Darwich AS,Galetin A,et al.Deconvolution and IVIVC:exploring the role of rate-limiting conditions[J].AAPS J,2016,18(2):321-332.
    [8]
    Hardikar S, Bhosale AV, Budhawant RN. Establishment of in vivo-in vitro correlation:a cogent strategy in product development process[J].Indian J Pharm Edu,2014,48(4):66-73.
    [9]
    Tsume Y, Mudie DM, Langguth P, et al. The Biopharmaceutics classification system:subclasses for in vivo predictive dissolution(IPD)methodology and IVIVC[J].Eur J Pharm Sci,2014,57(1):152-163.
    [10]
    Kumar V,Lalit Kumar K,Shavej A,et al.Application of assumed IVIVC in product life cycle management:a case study of trimetazidine dihydrochloride extended release tablet[J].J Bioequiv Availab,2013,5(1):006-015.
    [11]
    Suarez-Sharp S,Li M,Duan J,et al.Regulatory experience with in vivo in vitro correlations(IVIVC)in new drug applications[J].AAPS J,2016,18(6):1379-1390.
    [12]
    Rämsch KD,Graefe KH,Scherling D,et al.Pharmacokinetics and metabolism of calcium-blocking agents nifedipine,nitrendipine,and nimodipine[J].Am J Nephrol,1986,6(Suppl 1):73-80.
    [13]
    Gualano V,Ntsikoussalabongui B,Mignot A,et al.Comparative bioavailability of two oral nimodipine formulations after administration to 24 healthy volunteers[J].Clin Drug Invest,1999,17(6):475-482.
    [14]
    Serban C,Sahebkar A,Ursoniu S,et al.A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations[J].Sci Rep,2015,5(1):9902.
    [15]
    González-García I,Mangas-Sanjuán V,Merino-Sanjuán M,et al.In vitro-in vivo correlations:general concepts,methodologies and regulatory applications[J].Drug Dev Ind Pharm,2015,41(12):1935-1947.
    [16]
    Liu J,Ma MC,Chow SC.Statistical evaluation of similarity factor f2 as a criterion for assessment of similarity between dissolution profiles[J].Drug Inf J,1997,31(4):1255-1271.
    [17]
    Shah VP,Tsong Y,Sathe P,et al.In vitro dissolution profile comparison-statistics and analysis of the similarity factor,f2[J].Pharm Res,1998,15(6):889-896.
    [18]
    Tsong Y,Hammerstrom T,Sathe P,et al.Statistical assessment of mean differences between two dissolution data sets[J].Ther Innov Regul Sci,1996,30(4):1105-1112.
    [19]
    Zhang Y,Huo M,Zhou J,et al.DDSolver:an add-in program for modeling and comparison of drug dissolution profiles[J].AAPS J,2010,12(3):263-271.
    [20]
    Chinese Pharmacopoeia Commission.Chinese Pharmacopoeia:part 2(中华人民共和国药典:二部)[S].Beijing:China Medical Science Press,2015:309-310.
    [21]
    U.S.Food and Drug Administration.Guidance for industry.dissolution testing of immediate release solid oral dosage forms[EB/OL].https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm070237.pdf.
    [22]
    Cascone S,Lamberti G,Marra F,et al.Gastrointestinal behavior and ADME phenomena:I.In vitro simulation[J].J Drug Deliv Sci Technol,2016,35(5):272-283.
    [23]
    Xie MF.An understanding of "the quality consistency evaluation technique for oral solid pharmaceutical preparation"-multiple dissolution curves[J].Chin J Drug Eval(中国药物评价),2013,30(2):65-66.
    • Related Articles

  • Related Articles

    [1]LI Juanjuan, HUANG Yue, WANG Yahe, ZHANG Lianxiang, QIANG Yuanyuan, GUO Le, LIU Kunmei. Antiepileptic and neuroprotective mechanism of ursolic acid based on full-length transcriptome analysis[J]. Journal of China Pharmaceutical University, 2024, 55(4): 512-521. DOI: 10.11665/j.issn.1000-5048.2023111303
    [2]PEI Ting, WANG Yuying. Synthesis and preliminary anti-tumor activity of novel ursolic acid derivative-chalcone conjugates[J]. Journal of China Pharmaceutical University, 2017, 48(1): 31-41. DOI: 10.11665/j.issn.1000-5048.20170105
    [3]CHEN Hong, YANG Jie, CUI Wei-xi, WANG Qiang. Effects and mechanism of ursolic acid on lipopolysaccharide-induced THP-1 cells[J]. Journal of China Pharmaceutical University, 2011, 42(5): 447-451.
    [4]WANG Jing-song, SHEN Jing, ZHANG Ting, TANG Cong, REN Tian-nian, XI Tao. Ursolic acid downregulates COX-2 expression by suppressing the activation of ERK in A549 cells[J]. Journal of China Pharmaceutical University, 2011, 42(1): 68-72.
    [5]Inhibitory effects and mechanism of ursolic acid on the proliferation of rataortic smooth muscle cells[J]. Journal of China Pharmaceutical University, 2010, 41(1): 66-69.
    [6]ZHENG Kai-bo, SUN Cheng-bin, MAO Hai-li, YANG Zai-bo. Progress in the research of chemical structural modification of ursolic acid and structure-activity relationship[J]. Journal of China Pharmaceutical University, 2009, 40(6): 580-584.
    [7]Release and Identification of Monocrotalic Acid from Dehydromonocrotaline[J]. Journal of China Pharmaceutical University, 2003, (6): 18-21.
    [8]Cloning of Spinach Glycolate Oxidase cDNA and Its Construction into Yeast Expression Vector[J]. Journal of China Pharmaceutical University, 2003, (1): 83-86.
    [9]Cloning of S-adenosyl-L-methionine Synthetase Gene from Saccharomyces ceverisiae and its Expression in E.coli[J]. Journal of China Pharmaceutical University, 2002, (3): 87-89.
    [10]Determination of Four Acids Components in Keyoulin Liquid Using Derivatization by GC[J]. Journal of China Pharmaceutical University, 1998, (6): 453-455.

  • Cited by

    Periodical cited type(1)

    1. 朱灵英，郭娟，张爱丽，王宝婕，曾礼芳，徐福荣，马晓惠. 参与植物三萜生物合成的细胞色素P450酶研究进展. 中草药. 2019(22): 5597-5610 .

    Other cited types(3)

Catalog

    Get Citation
    PDF
    XML
    Article views (984) PDF downloads (1652) Cited by(4)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：318963

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return